# A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers

> **NCT02403713** · PHASE1 · COMPLETED · sponsor: **Mundipharma Research Limited** · enrollment: 125 (estimated)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fluticasone/formoterol BAI
- **DRUG:** Formoterol
- **DRUG:** Fluticasone/formoterol PMDI without spacer
- **DRUG:** Fluticasone/formoterol PMDI with spacer
- **DRUG:** Fluticasone/formoterol PMDI without spacer low dose

## Key facts

- **NCT ID:** NCT02403713
- **Lead sponsor:** Mundipharma Research Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2014-10
- **Final completion:** 2015-09
- **Target enrollment:** 125 (ESTIMATED)
- **Last updated:** 2015-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02403713

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02403713, "A Pharmacokinetic/Pharmacodynamic Inhaler Comparison Study in Healthy Volunteers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02403713. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*